Evidence map›Paper›PMID 37786521›Full record

ArticleIbrain2023

Effect of sulfonamide derivatives of

Ankit Ganeshpurkar, Ravi Singh, Pratigya Tripathi, Qadir Alam, Sairam Krishnamurthy, Ashok Kumar, Sushil K Singh

Open access · goldAbstract read
In one paragraph

Article in Ibrain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.Central nervous system agents in medicinal chemistry · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ankit GaneshpurkarDepartment of Pharmaceutical Engineering and Technology, Pharmaceutical Chemistry Research Laboratory I Indian Institute of Technology (Banaras Hindu University) Varanasi India.
Ravi SinghDepartment of Pharmaceutical Engineering and Technology, Pharmaceutical Chemistry Research Laboratory I Indian Institute of Technology (Banaras Hindu University) Varanasi India.
Pratigya TripathiDepartment of Pharmaceutical Engineering and Technology, Neurotherapeutics Laboratory Indian Institute of Technology (Banaras Hindu University) Varanasi Uttar Pradesh India.
Qadir AlamDepartment of Pharmaceutical Engineering and Technology, Neurotherapeutics Laboratory Indian Institute of Technology (Banaras Hindu University) Varanasi Uttar Pradesh India.
Sairam KrishnamurthyDepartment of Pharmaceutical Engineering and Technology, Neurotherapeutics Laboratory Indian Institute of Technology (Banaras Hindu University) Varanasi Uttar Pradesh India.
Ashok KumarDepartment of Pharmaceutical Engineering and Technology, Pharmaceutical Chemistry Research Laboratory I Indian Institute of Technology (Banaras Hindu University) Varanasi India.
Sushil K SinghDepartment of Pharmaceutical Engineering and Technology, Pharmaceutical Chemistry Research Laboratory I Indian Institute of Technology (Banaras Hindu University) Varanasi India.ORCID 0000-0003-0473-5824
Indian Institute of Technology Indore · INBanaras Hindu University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is a neurodegenerative disease responsible for dementia and other neuropsychiatric symptoms. In the present study, compounds

Indexed as

amnesiabutyrylcholinesterasedockingscopolaminesulfonamide

Identifiers

PMID37786521
PMCPMC10529173
OpenAlexW4320729215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.